Iron Deficiency Common, Often Persistent
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, Aug. 15, 2024 -- Iron deficiency (ID) is common in an American statewide health system, and the time to resolution is prolonged, according to a study published online Aug. 15 in Blood Advances.
Jacob C. Cogan, M.D., from the University of Minnesota in Minneapolis, and colleagues conducted a retrospective review of electronic medical record data from a Minnesota statewide health system and identified patients with ID (ferritin level ≤25 ng/mL). Participants had at least one follow-up ferritin level within three years. Resolved ID was classified as having a subsequent ferritin level ≥50 ng/mL. Data were included for 13,084 patients with ID between 2010 and 2020.
The researchers found that 41.9 percent of patients had resolution within three years of diagnosis (median time to resolution, 1.9 years), and 58.1 percent had no documented resolution. Age 60 years and older, male sex, and treatment with intravenous iron were factors associated with a greater likelihood of resolution (adjusted hazard ratios, 1.56, 1.58, and 2.96, respectively). A lower likelihood of resolution was seen in association with Black race (adjusted hazard ratio, 0.73).
"Iron deficiency can be challenging to diagnose, but it's easy to treat," Cogan said in a statement. "Our findings underscore the need for a more coordinated effort to recognize and treat iron deficiency to help improve quality of life."
Two authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-08-16 01:15
Read more
- Abeona Therapeutics Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration
- High Rates of Hep C Seen for Patients Presenting to ED With Opioid Overdose
- Fine Particulate Matter Linked to Increased Incidence of Head, Neck Cancer
- More Than Four in 10 U.S. Adults Have Fatty Liver Disease
- Overtreatment Common for Older Men With Prostate Cancer
- UCB Receives U.S. FDA Approval for Bimzelx (bimekizumab-bkzx) as the First IL-17A and IL-17F Inhibitor for Adults with Moderate to Severe Hidradenitis Suppurativa
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions